Evidence map›Paper›PMID 32420253›Full record

ArticleGland surgery2020

Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas.

Dongliang Bian, Liting Zhao, Xuelin Zhang, Fanzhen Lv, Zhenghong Zhu, Hui Qiu, Huibiao Zhang

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dongliang BianDepartment of Thoracic Surgery, Fudan University Affiliated Huadong Hospital, Shanghai 200040, China.
Liting ZhaoDepartment of Thoracic Surgery, Fudan University Affiliated Huadong Hospital, Shanghai 200040, China.
Xuelin ZhangDepartment of Thoracic Surgery, Fudan University Affiliated Huadong Hospital, Shanghai 200040, China.
Fanzhen LvDepartment of Thoracic Surgery, Fudan University Affiliated Huadong Hospital, Shanghai 200040, China.
Zhenghong ZhuDepartment of Thoracic Surgery, Fudan University Affiliated Huadong Hospital, Shanghai 200040, China.
Hui QiuDepartment of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Huibiao ZhangDepartment of Thoracic Surgery, Fudan University Affiliated Huadong Hospital, Shanghai 200040, China.
Huadong Hospital · CNFudan University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThymomas are rare malignancies. Thymectomy is the optimal therapy which could prolong the survival of patients. However, prognostic factors of thymomas are not clear.

methodsThymomas patients were enrolled from 2001 to 2016. Clinical and pathological prognostic factors of thymomas were evaluated by univariate and multivariate analyses.

resultsA total number of 98 patients was eligible for this study. All patients were received complete resection (CR). Diagnostic age [elder than the median 60

conclusionsWe found that diagnostic age, clinical stages, DM, TP53 expression in IHC, and quality perioperative nursing are prognostic factors in thymomas.

Indexed as

surgeryThymomasTP53

Identifiers

PMID32420253
PMCPMC7225485
OpenAlexW3010249041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.